These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 21850692

  • 1. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
    Kornberg A, Küpper B, Tannapfel A, Büchler P, Krause B, Witt U, Gottschild D, Friess H.
    Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
    [Abstract] [Full Text] [Related]

  • 2. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
    Hong G, Suh KS, Suh SW, Yoo T, Kim H, Park MS, Choi Y, Paeng JC, Yi NJ, Lee KW.
    J Hepatol; 2016 Apr; 64(4):852-9. PubMed ID: 26658686
    [Abstract] [Full Text] [Related]

  • 3. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
    Takada Y, Kaido T, Shirabe K, Nagano H, Egawa H, Sugawara Y, Taketomi A, Takahara T, Wakabayashi G, Nakanishi C, Kawagishi N, Kenjo A, Gotoh M, Toyoki Y, Hakamada K, Ohtsuka M, Akamatsu N, Kokudo N, Takeda K, Endo I, Takamura H, Okajima H, Wada H, Kubo S, Kuramitsu K, Ku Y, Ishiyama K, Ohdan H, Ito E, Maehara Y, Honda M, Inomata Y, Furukawa H, Uemoto S, Yamaue H, Miyazaki M, Takada T, LTx-PET study group of the Japanese Society of Hepato-Biliary-Pancreatic Surgery and the Japanese Liver Transplantation Society.
    J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Lee SD, Kim SH, Kim SK, Kim YK, Park SJ.
    Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
    [Abstract] [Full Text] [Related]

  • 6. Role of [18F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma.
    Ye YF, Wang W, Wang T, Yu J, Geng L, Yu SF, Yan S, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
    [Abstract] [Full Text] [Related]

  • 7. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma.
    Kornberg A, Witt U, Schernhammer M, Kornberg J, Ceyhan GO, Mueller K, Friess H, Thrum K.
    Sci Rep; 2017 Oct 26; 7(1):14176. PubMed ID: 29074969
    [Abstract] [Full Text] [Related]

  • 8. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT, Ho CL, Lo CM, Chen S, Chan SC, Chok KS, Fung JY, Yan Chan AC, Sharr W, Yau T, Poon RT, Fan ST.
    J Nucl Med; 2013 Feb 26; 54(2):192-200. PubMed ID: 23321459
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
    Detry O, Govaerts L, Deroover A, Vandermeulen M, Meurisse N, Malenga S, Bletard N, Mbendi C, Lamproye A, Honoré P, Meunier P, Delwaide J, Hustinx R.
    World J Gastroenterol; 2015 Mar 14; 21(10):3049-54. PubMed ID: 25780305
    [Abstract] [Full Text] [Related]

  • 10. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
    Cheung TT, Chan SC, Ho CL, Chok KS, Chan AC, Sharr WW, Ng KK, Poon RT, Lo CM, Fan ST.
    Liver Transpl; 2011 Oct 14; 17(10):1218-25. PubMed ID: 21688383
    [Abstract] [Full Text] [Related]

  • 11. Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
    Kornberg A, Witt U, Kornberg J, Friess H, Thrum K.
    Dig Dis Sci; 2015 Sep 14; 60(9):2832-9. PubMed ID: 25630421
    [Abstract] [Full Text] [Related]

  • 12. Pretransplant serum levels of C-reactive protein predict prognoses in patients undergoing liver transplantation for hepatocellular carcinoma.
    Kim YK, Kim SH, Lee SD, Hong SK, Park SJ.
    Transplant Proc; 2015 Apr 14; 47(3):686-93. PubMed ID: 25891712
    [Abstract] [Full Text] [Related]

  • 13. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH.
    Clin Nucl Med; 2017 Apr 14; 42(4):e183-e187. PubMed ID: 28114226
    [Abstract] [Full Text] [Related]

  • 14. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
    Pant V, Sen IB, Soin AS.
    Nucl Med Commun; 2013 Aug 14; 34(8):749-57. PubMed ID: 23689586
    [Abstract] [Full Text] [Related]

  • 15. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
    Lee JW, Paeng JC, Kang KW, Kwon HW, Suh KS, Chung JK, Lee MC, Lee DS.
    J Nucl Med; 2009 May 14; 50(5):682-7. PubMed ID: 19372474
    [Abstract] [Full Text] [Related]

  • 16. [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
    Asman Y, Evenson AR, Even-Sapir E, Shibolet O.
    Liver Transpl; 2015 May 14; 21(5):572-80. PubMed ID: 25644857
    [Abstract] [Full Text] [Related]

  • 17. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ.
    Liver Transpl; 2010 Jun 14; 16(6):767-72. PubMed ID: 20517911
    [Abstract] [Full Text] [Related]

  • 18. Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC.
    Kornberg A, Witt U, Matevossian E, Küpper B, Assfalg V, Drzezga A, Hüser N, Wildgruber M, Friess H.
    PLoS One; 2013 Jun 14; 8(1):e53960. PubMed ID: 23349774
    [Abstract] [Full Text] [Related]

  • 19. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
    Lee SD, Kim SH, Kim YK, Kim C, Kim SK, Han SS, Park SJ.
    Transpl Int; 2013 Jan 14; 26(1):50-60. PubMed ID: 23106431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.